Planet 13 Holdings (PLNH) Asset Writedowns and Impairment (2021 - 2025)

Planet 13 Holdings' (PLNH) quarterly Asset Writedowns and Impairment came in at $11.7 million in Q4 2025, up 1284.67% year-on-year from $846449.0 in Q4 2024, and up 100.01% on a QoQ basis from $5.9 million in Q3 2025.

Planet 13 Holdings (PLNH) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends

Planet 13 Holdings (PLNH) has 5 years of Asset Writedowns and Impairment data on file, last reported at $11.7 million in Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 1284.67% year-over-year to $11.7 million in Q4 2025; TTM through Dec 2025 was $20.1 million, a 59.33% decrease from a year earlier, with the FY2025 full-year figure at $17.6 million, up 442.69% from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 stood at $11.7 million, up from $5.9 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for PLNH reached as high as $46.8 million in Q4 2023 and fell as low as -$3.3 million in Q4 2021.
  • Historically, Asset Writedowns and Impairment has averaged $5.7 million across 5 years, with a median of $950585.0 in 2022.
  • Across the five-year window, Asset Writedowns and Impairment slumped 162.1% in 2022 and jumped 1284.67% in 2025, its largest moves.
  • Year by year, Asset Writedowns and Impairment stood at -$3.3 million in 2021, then surged by 308.46% to $6.9 million in 2022, then jumped by 574.27% to $46.8 million in 2023, then slumped by 98.19% to $846449.0 in 2024, then soared by 1284.67% to $11.7 million in 2025.
  • Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $11.7 million in Q4 2025, $5.9 million in Q3 2025, and $846449.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.06 Bn 87.19 Bn -
2 Teva Pharmaceutical Industries 35.81 Bn 32.07 Bn 1.97 Bn
3 Zoetis 32.50 Bn 30.56 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.51 Bn 23.45 Bn 4.39 Bn
5 United Therapeutics 23.19 Bn 21.04 Bn 648.10 Mn
6 RedHill Biopharma 21.76 Bn 21.76 Bn -
7 Viatris 20.28 Bn 18.47 Bn 1.16 Bn
8 Neurocrine Biosciences 17.72 Bn 16.40 Bn 800.70 Mn
9 Elanco Animal Health 12.56 Bn 12.13 Bn 785.00 Mn
10 Planet 13 Holdings 38.53 Mn 22.27 Mn 9.41 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 11.72 Mn
Dec 31, 2025 11.72 Mn
Sep 30, 2025 5.86 Mn
Sep 30, 2025 5.86 Mn
Dec 31, 2024 846,449.00
Dec 31, 2024 846,449.00
Sep 30, 2024 1.63 Mn
Sep 30, 2024 1.63 Mn
Dec 31, 2023 46.85 Mn
Dec 31, 2023 46.85 Mn
Dec 31, 2022 6.95 Mn
Dec 31, 2022 6.95 Mn
Sep 30, 2022 -1.80 Mn
Sep 30, 2022 -1.80 Mn
Jun 30, 2022 849,008.00
Jun 30, 2022 849,008.00
Mar 31, 2022 950,585.00
Mar 31, 2022 950,585.00
Dec 31, 2021 -3.33 Mn
Dec 31, 2021 -3.33 Mn